SCHEDULE 13D

Company

Eloxx Pharmaceuticals, Inc.

Filed

January 10, 2002

Accession Number

0000950136-02-000093

A Schedule 13D is filed when an investor acquires more than 5% of a company's shares with an intent to influence control. Learn more about SC 13D filings →